LIVE990x200
If you have already registered, please check your email for the webinar link.

Ultra-Rapid Droplet Digital PCR: Tumor Samples to Results in 15 Minutes

The diagnosis and treatment of tumors critically depend on molecular-genetic data, but this information is not currently available during surgery. Dr. Evrony’s group, in collaboration with neurosurgeon Dr. Daniel Orringer, developed Ultra-Rapid droplet digital PCR (UR-ddPCR). This method allows for ddPCR to be performed in 15 minutes, from tissue to result, with an accuracy comparable to standard ddPCR. We developed UR-ddPCR assays for the IDH1 R132H and BRAF V600E clonal mutations that are present in many low-grade gliomas and melanomas, respectively.

Importantly, we demonstrated the clinical feasibility of UR-ddPCR by performing it intraoperatively in 13 glioma surgeries. Join us for this webinar, as well as the live Q&A, and discover how UR-ddPCR may enable new types of point-of-care diagnostics and molecularly guided surgeries.

calendar-iconfinal

 

Thursday, August 1, 2024

clock icon

 

1:00 PM EDT
 


Speakers

Andrew Dix.jpg
Dr. Gilad D. Evrony, MD, PhD
Assistant Professor
NYU School of Medicine’s Center for Human Genetics and Genomics


Register Now!

You must have Javascript and Cookies enabled to access this webcast.